Literature DB >> 9616363

Human monoclonal antibodies specific to hepatitis B virus generated in a human/mouse radiation chimera: the Trimera system.

R Eren1, I Lubin, D Terkieltaub, O Ben-Moshe, A Zauberman, R Uhlmann, T Tzahor, S Moss, E Ilan, D Shouval, E Galun, N Daudi, H Marcus, Y Reisner, S Dagan.   

Abstract

An approach to develop fully human monoclonal antibodies in a human/mouse radiation chimera, the Trimera system, is described. In this system, functional human lymphocytes are engrafted in normal strains of mice which are rendered immuno-incompetent by lethal total body irradiation followed by radioprotection with severe combined immunodeficient (SCID) mouse bone marrow. Following transplantation, human lymphocytes colonize murine lymphatic organs and secrete human immunoglobulins. We have established this system as a tool to develop fully human monoclonal antibodies, and applied it for the generation of monoclonal antibodies specific for hepatitis B virus surface antigen. A strong memory response to hepatitis B surface antigen was elicited in Trimera engrafted with lymphocytes from human donors positive for antibodies to hepatitis B surface antigen. The human specific antibody fraction in the Trimera was 10(2)-10(3)-fold higher as compared with that found in the donors. Spleens were harvested from Trimera mice showing high specific-antibody titres and cells were fused to a human-mouse heteromyeloma fusion partner. Several stable hybridoma clones were isolated and characterized. These hybridomas produce high-affinity, IgG, anti-hepatitis B surface antigen antibodies demonstrating the potential of the Trimera system for generating fully human monoclonal antibodies. The biological function and the neutralizing activity of these antibodies are currently being tested.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9616363      PMCID: PMC1364173          DOI: 10.1046/j.1365-2567.1998.00426.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  32 in total

1.  Phage antibodies: filamentous phage displaying antibody variable domains.

Authors:  J McCafferty; A D Griffiths; G Winter; D J Chiswell
Journal:  Nature       Date:  1990-12-06       Impact factor: 49.962

2.  Human monoclonal antibodies to C, c, E, e and G antigens of the Rh system.

Authors:  K Thompson; G Barden; J Sutherland; I Beldon; M Melamed
Journal:  Immunology       Date:  1990-11       Impact factor: 7.397

3.  EB virus-induced B lymphocyte cell lines producing specific antibody.

Authors:  M Steinitz; G Klein; S Koskimies; O Makel
Journal:  Nature       Date:  1977-09-29       Impact factor: 49.962

Review 4.  Man-made antibodies.

Authors:  G Winter; C Milstein
Journal:  Nature       Date:  1991-01-24       Impact factor: 49.962

Review 5.  The Croonian lecture, 1989. Antibodies: a paradigm for the biology of molecular recognition.

Authors:  C Milstein
Journal:  Proc R Soc Lond B Biol Sci       Date:  1990-02-22

6.  High efficiency fusion procedure for producing monoclonal antibodies against weak immunogens.

Authors:  R D Lane; R S Crissman; S Ginn
Journal:  Methods Enzymol       Date:  1986       Impact factor: 1.600

7.  Measurements of the true affinity constant in solution of antigen-antibody complexes by enzyme-linked immunosorbent assay.

Authors:  B Friguet; A F Chaffotte; L Djavadi-Ohaniance; M E Goldberg
Journal:  J Immunol Methods       Date:  1985-03-18       Impact factor: 2.303

8.  Immunization against hepatitis B: report on a WHO meeting on viral hepatitis in Europe.

Authors:  F Deinhardt; A J Zuckerman
Journal:  J Med Virol       Date:  1985-11       Impact factor: 2.327

9.  A humanized antibody that binds to the interleukin 2 receptor.

Authors:  C Queen; W P Schneider; H E Selick; P W Payne; N F Landolfi; J F Duncan; N M Avdalovic; M Levitt; R P Junghans; T A Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

10.  Limited B cell repertoire in severe combined immunodeficient mice engrafted with peripheral blood mononuclear cells derived from immunodeficient or normal humans.

Authors:  A Saxon; E Macy; K Denis; M Tary-Lehmann; O Witte; J Braun
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

View more
  13 in total

Review 1.  Mining human antibody repertoires.

Authors:  Roger R Beerli; Christoph Rader
Journal:  MAbs       Date:  2010-07-01       Impact factor: 5.857

2.  Novel mechanism of antibodies to hepatitis B virus in blocking viral particle release from cells.

Authors:  Avidan U Neumann; Sandra Phillips; Idit Levine; Samreen Ijaz; Harel Dahari; Rachel Eren; Shlomo Dagan; Nikolai V Naoumov
Journal:  Hepatology       Date:  2010-09       Impact factor: 17.425

3.  A Combination of Human Broadly Neutralizing Antibodies against Hepatitis B Virus HBsAg with Distinct Epitopes Suppresses Escape Mutations.

Authors:  Qiao Wang; Eleftherios Michailidis; Yingpu Yu; Zijun Wang; Arlene M Hurley; Deena A Oren; Christian T Mayer; Anna Gazumyan; Zhenmi Liu; Yunjiao Zhou; Till Schoofs; Kai-Hui Yao; Jan P Nieke; Jianbo Wu; Qingling Jiang; Chenhui Zou; Mohanmmad Kabbani; Corrine Quirk; Thiago Oliveira; Kalsang Chhosphel; Qianqian Zhang; William M Schneider; Cyprien Jahan; Tianlei Ying; Jill Horowitz; Marina Caskey; Mila Jankovic; Davide F Robbiani; Yumei Wen; Ype P de Jong; Charles M Rice; Michel C Nussenzweig
Journal:  Cell Host Microbe       Date:  2020-06-05       Impact factor: 21.023

4.  Preclinical evaluation of two neutralizing human monoclonal antibodies against hepatitis C virus (HCV): a potential treatment to prevent HCV reinfection in liver transplant patients.

Authors:  Rachel Eren; Dorit Landstein; Dov Terkieltaub; Ofer Nussbaum; Arie Zauberman; Judith Ben-Porath; Judith Gopher; Rachel Buchnick; Riva Kovjazin; Ziva Rosenthal-Galili; Sigal Aviel; Ehud Ilan; Yariv Shoshany; Lewis Neville; Tal Waisman; Ofer Ben-Moshe; Alberto Kischitsky; Steven K H Foung; Zhen-Yong Keck; Orit Pappo; Ahmed Eid; Oded Jurim; Gidi Zamir; Eithan Galun; Shlomo Dagan
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

5.  Antigen-specific B and T cells in human/mouse radiation chimera following immunization in vivo.

Authors:  W O Böcher; H Marcus; R Shakarchy; B Dekel; D Shouval; E Galun; Y Reisner
Journal:  Immunology       Date:  1999-04       Impact factor: 7.397

6.  Efficient generation of respiratory syncytial virus (RSV)-neutralizing human MoAbs via human peripheral blood lymphocyte (hu-PBL)-SCID mice and scFv phage display libraries.

Authors:  H Nguyen; J Hay; T Mazzulli; S Gallinger; J Sandhu; Y Teng; N Hozumi
Journal:  Clin Exp Immunol       Date:  2000-10       Impact factor: 4.330

7.  Modification of Asparagine-Linked Glycan Density for the Design of Hepatitis B Virus Virus-Like Particles with Enhanced Immunogenicity.

Authors:  Michiko Hyakumura; Renae Walsh; Morten Thaysen-Andersen; Natalie J Kingston; Mylinh La; Louis Lu; George Lovrecz; Nicolle H Packer; Stephen Locarnini; Hans J Netter
Journal:  J Virol       Date:  2015-09-02       Impact factor: 5.103

8.  Involvement of IL-10 in the suppression of antibody production by in vitro immunized peripheral blood mononuclear cells.

Authors:  Makiko Yamashita; Yoshinori Katakura; Yoshihiro Aiba; Shin-Ei Matsumoto; Kazuko Morihara; Kiichiro Teruya; Akira Ichikawa; Sanetaka Shirahata
Journal:  Cytotechnology       Date:  2007-08-14       Impact factor: 2.058

9.  Chronic Schistosoma japonicum infection reduces immune response to vaccine against hepatitis B in mice.

Authors:  Lin Chen; Wen-qi Liu; Jia-hui Lei; Fei Guan; Man-jun Li; Wen-jian Song; Yong-long Li; Ting Wang
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

10.  Recent advances in the study of human antibody responses to influenza virus using optimized human hybridoma approaches.

Authors:  James E Crowe
Journal:  Vaccine       Date:  2009-12-30       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.